Abpro Holdings, Inc
Ticker(s):
ABP and ABPWW
Country:
Sector & Industry:
Business Overview
Abpro Holdings, Inc., a biotechnology company, provides antibody therapeutics for cancer related issues. Its platform DiversImmune addresses the antibody therapeutics. The company’s product candidates include ABP-102 for the treatment of breast and gastric cancer; and ABP-110 for the treatment of liver cancer. It also offers ABP-105 for the treatment of gastric cancer and ABP 201 for vascular diseases of the eye and diabetic macular edema. Abpro Holdings, Inc. was incorporated in 2004 and is based in Woburn, Massachusetts.
Contact & Other Information
Number of Employees:
15
Website:
68 Cummings Park Drive
Woburn
,
MA
,
01801
United States
800 396 5890
02/21/2025 | 8-K | 0001213900-25-016110 |
Abpro Holdings, Inc. provided an investor presentation with updates on its pipeline and partnerships.